You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 22, December 14, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Radiologic Imaging
 •Computed Tomography
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Electron-Beam Computed Tomography for Coronary Calcium

A Useful Test to Screen for Coronary Heart Disease?

Dariush Mozaffarian, MD, MPH

JAMA. 2005;294:2897-2901.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Electron-beam computed tomography (EBCT) uses x-rays generated by electron-beam irradiation of a tungsten target to identify and quantify coronary artery calcium (CAC).1 Initial studies focused on the use of EBCT for risk stratification or diagnosis among individuals with clinical symptoms of coronary heart disease (CHD).1-3 However, more recent articles,4-14 as well as marketing by for-profit companies,15-16 have focused on using EBCT for screening; that is, for detection of CHD in asymptomatic individuals.

When considering the potential value of EBCT for screening, it is critical to keep in mind generally accepted principles for what constitutes an effective screening test17-18:

Disease.—The disease should be common and of public health consequence, have an extended preclinical stage, and result in preventable morbidity or mortality.
Diagnosis.—The screening test must accurately classify asymptomatic individuals in the population of interest as likely to have or not have the disease.
Therapy.—Detection of subclinical . . . [Full Text of this Article]

CHD as a Target for Screening

Author Affiliations: Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, and the Harvard School of Public Health, Boston, Mass.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Educational inequalities in self-rated health within the Arab minority in Israel: explanatory factors
Daoud et al.
Eur J Public Health 2009;19:477-483.
ABSTRACT | FULL TEXT  

Transforming Clinical Practice Guidelines Into Legislative Mandates: Proceed With Abundant Caution
Jacobson
JAMA 2008;299:208-210.
FULL TEXT  

Prediction of Coronary Artery Calcium in Young Adults Using the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Risk Score: The CARDIA Study
Gidding et al.
Arch Intern Med 2006;166:2341-2347.
ABSTRACT | FULL TEXT  

A 39-year-old woman with hypercholesterolemia.
Mittleman
JAMA 2006;296:319-326.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.